
Sicagen India Sees Revision in Market Assessment Amidst Challenging Financial Trends
2025-12-03 11:08:25Sicagen India, a microcap player in the Trading & Distributors sector, has experienced a revision in its market evaluation reflecting shifts in its financial and technical outlook. The recent assessment highlights a complex interplay of valuation appeal, subdued financial momentum, and technical indicators that have influenced the stock’s market perception.
Read More
Sicagen India Forms Death Cross Signalling Potential Bearish Trend
2025-11-18 18:01:08Sicagen India, a micro-cap player in the Trading & Distributors sector, has recently formed a Death Cross, a significant technical event where the 50-day moving average (DMA) crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a potential weakening in the stock’s medium to long-term momentum.
Read MoreWhy is Sicagen India falling/rising?
2025-11-10 22:10:29As of 10-Nov, Sicagen India Ltd is currently priced at 61.90, reflecting an increase of 0.42 or 0.68%. Despite this positive movement today, the stock has underperformed in the short term, with a 1-week decline of 2.78% and a 1-month decrease of 4.21%. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. However, there has been a notable rise in investor participation, with delivery volume increasing by 151.7% compared to the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement. In the broader market context, Sicagen India has outperformed its sector today by 3.39%, even as the sector itself has seen a decline of 2.74%. When comparing the stock's performance to the benchmark Sensex, Sicagen has faced significant challenges, with a year-t...
Read MoreBoard Meeting Outcome for Outcome Of The Board Meeting Dated 30Th January 2026
30-Jan-2026 | Source : BSEOutcome of the Board meeting dated 30th January 2026
Un-Audited Financial Results For The Quarter & Nine Months Period Ended 31.12.2025
30-Jan-2026 | Source : BSEUn-audited Financial Results (both Standalone & Consolidated) of the Company for the quarter & nine months ended 31.12.2025.
Board Meeting Intimation for For Consideration And Approval Of The Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December 2025.
23-Jan-2026 | Source : BSESicagen India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 inter alia to consider and approve the Un-audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter and Nine Months ended 31st December 2025.
Corporate Actions
No Upcoming Board Meetings
Sicagen India Ltd has declared 10% dividend, ex-date: 23 Sep 25
No Splits history available
No Bonus history available
No Rights history available